JP2021502423A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502423A5 JP2021502423A5 JP2020545225A JP2020545225A JP2021502423A5 JP 2021502423 A5 JP2021502423 A5 JP 2021502423A5 JP 2020545225 A JP2020545225 A JP 2020545225A JP 2020545225 A JP2020545225 A JP 2020545225A JP 2021502423 A5 JP2021502423 A5 JP 2021502423A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- interleukin
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762584999P | 2017-11-13 | 2017-11-13 | |
| US62/584,999 | 2017-11-13 | ||
| US201862629473P | 2018-02-12 | 2018-02-12 | |
| US62/629,473 | 2018-02-12 | ||
| US201862679576P | 2018-06-01 | 2018-06-01 | |
| US62/679,576 | 2018-06-01 | ||
| US201862712457P | 2018-07-31 | 2018-07-31 | |
| US62/712,457 | 2018-07-31 | ||
| PCT/US2018/060699 WO2019094916A1 (en) | 2017-11-13 | 2018-11-13 | Methods and compositions for treating cancer by modifying multiple arms of the immune system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502423A JP2021502423A (ja) | 2021-01-28 |
| JP2021502423A5 true JP2021502423A5 (https=) | 2021-12-23 |
Family
ID=66439031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545225A Pending JP2021502423A (ja) | 2017-11-13 | 2018-11-13 | 免疫系の複数のアームを修飾することによってがんを治療するための方法及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200317784A1 (https=) |
| EP (1) | EP3710035A4 (https=) |
| JP (1) | JP2021502423A (https=) |
| AU (1) | AU2018364752A1 (https=) |
| BR (1) | BR112020009363A2 (https=) |
| CA (1) | CA3082117A1 (https=) |
| MX (1) | MX2020004914A (https=) |
| WO (1) | WO2019094916A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2991628C (en) | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| US20210038684A1 (en) | 2019-06-11 | 2021-02-11 | Alkermes Pharma Ireland Limited | Compositions and Methods for Cancer Immunotherapy |
| BR112022007158A2 (pt) | 2019-10-18 | 2022-07-05 | Alkermes Pharma Ireland Ltd | Agentes imunomodulatórios de il-2 em combinação com inibidores do ponto de verificação imunológico |
| US20220370563A1 (en) * | 2019-10-25 | 2022-11-24 | Neoleukin Therapeutics, Inc. | Methods of administration of il-2 receptor agonists |
| AU2020414355A1 (en) * | 2019-12-24 | 2022-08-11 | Neoleukin Therapeutics, Inc. | Combination therapy using an IL-2 receptor agonist and an immune checkpoint inhibitor |
| WO2021202923A1 (en) * | 2020-04-02 | 2021-10-07 | Nektar Therapeutics | Immunomodulator for the prevention and treatment of coronovirus infection and other conditions |
| PE20231648A1 (es) * | 2020-04-22 | 2023-10-17 | Merck Sharp And Dohme Llc | CONJUGADOS DE INTERLEUCINA 2 HUMANA SESGADOS AL DIMERO DEL RECEPTOR DE INTERLEUCINA 2 byc Y CONJUGADOS CON UN POLIMERO HIDROSOLUBLE NO PEPTIDICO |
| US20220257759A1 (en) * | 2021-02-17 | 2022-08-18 | Bioxcel Therapeutics, Inc. | Treatment of sarcoma using immunomodulation |
| WO2024097856A1 (en) * | 2022-11-03 | 2024-05-10 | Onkosxcel Therapeutics, Llc | Predictive biomarkers for responsiveness to dpp inhibitors in cancers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007058957A2 (en) * | 2005-11-10 | 2007-05-24 | Point Therapeutics, Inc | Boroproline compound and cytokine combination therapy |
| ES2738582T3 (es) * | 2014-02-14 | 2020-01-23 | Immune Design Corp | Inmunoterapia del cáncer a través de combinación de inmunoestimulación local y sistémica |
| KR102410090B1 (ko) * | 2014-02-21 | 2022-06-16 | 넥타르 테라퓨틱스 (인디아) 프라이빗 리미티드 | 항-ｃｔｌａ－４ 항체 또는 항-ｐｄ－１ 항체와 조합한 ｉｌ－２ｒ베타-선택적 효현제 |
| CA2991628C (en) * | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| KR20180040706A (ko) * | 2015-09-01 | 2018-04-20 | 인네이트 튜머 이뮤니티, 인코포레이티드 | 면역억제 시토카인에 대해 증가된 면역 또는 저항성을 갖는 면역 세포 및 그의 용도 |
| US10612005B2 (en) * | 2016-01-08 | 2020-04-07 | Replimune Limited | Modified oncolytic virus |
-
2018
- 2018-11-13 EP EP18875308.1A patent/EP3710035A4/en not_active Withdrawn
- 2018-11-13 WO PCT/US2018/060699 patent/WO2019094916A1/en not_active Ceased
- 2018-11-13 AU AU2018364752A patent/AU2018364752A1/en not_active Abandoned
- 2018-11-13 US US16/763,378 patent/US20200317784A1/en not_active Abandoned
- 2018-11-13 JP JP2020545225A patent/JP2021502423A/ja active Pending
- 2018-11-13 CA CA3082117A patent/CA3082117A1/en active Pending
- 2018-11-13 BR BR112020009363-7A patent/BR112020009363A2/pt not_active IP Right Cessation
- 2018-11-13 MX MX2020004914A patent/MX2020004914A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502423A5 (https=) | ||
| JP2020510662A5 (https=) | ||
| JP2023130496A (ja) | 癌治療のための併用療法 | |
| TWI808055B (zh) | Hdac 抑制劑與 pd-1 抑制劑之組合治療 | |
| JP2021102627A5 (https=) | ||
| JP2019510832A5 (https=) | ||
| JP2022088662A (ja) | ツカレゾールまたはそのアナログを含む組成物 | |
| JP2017506234A5 (https=) | ||
| JP2023098947A5 (https=) | ||
| JP2017537090A5 (https=) | ||
| JP2019501204A5 (https=) | ||
| JP2019518741A5 (https=) | ||
| KR20190022520A (ko) | Hdac 억제제 및 pd-l1 억제제의 병용 요법 | |
| JP2020502271A5 (https=) | ||
| JP2017507990A5 (https=) | ||
| Heckmann et al. | CXCR4 expression and treatment with SDF-1α or plerixafor modulate proliferation and chemosensitivity of colon cancer cells | |
| JP2015534577A5 (https=) | ||
| ES2946472T3 (es) | Agente antitumoral y potenciador del efecto antitumoral | |
| JP2018507197A5 (https=) | ||
| JP2017533266A5 (https=) | ||
| JP2008506681A5 (https=) | ||
| JP2018516966A5 (https=) | ||
| RU2018105985A (ru) | Новый подход к лечению рака с применением иммуномодуляции | |
| KR20210099074A (ko) | 방사성면역접합체와 dna 손상 및 복구 억제제의 조합 요법 | |
| JP2015529641A5 (https=) |